Table 2.
Signaling pathways through the identification of differentially expressed genes based on RNA sequencing
| Term | Count | Count% | p-value | FDR | Fold Enrichment |
|---|---|---|---|---|---|
| hsa05200: Pathways in cancer | 48 | 4.968944 | 1.45E-04 | 0.007682 | 1.75848474 |
| hsa05165: Human papillomavirus infection | 37 | 3.830228 | 1.35E-05 | 0.001788 | 2.17453107 |
| hsa04151: PI3K-Akt signaling pathway | 31 | 3.20911 | 0.004453535 | 0.051312 | 1.70353209 |
| hsa04010: MAPK signaling pathway | 28 | 2.898551 | 0.002269414 | 0.037587 | 1.85268928 |
| hsa05169: Epstein-Barr virus infection | 25 | 2.587992 | 9.75E-05 | 0.007682 | 2.40757889 |
| hsa04015: Rap1 signaling pathway | 25 | 2.587992 | 1.79E-04 | 0.007905 | 2.3158616 |
| hsa05132: Salmonella infection | 25 | 2.587992 | 0.002088988 | 0.037587 | 1.95313629 |
| hsa04060: Cytokine-cytokine receptor interaction | 25 | 2.587992 | 0.01660764 | 0.106027 | 1.64857944 |
| hsa04080: Neuroactive ligand-receptor interaction | 25 | 2.587992 | 0.095004708 | 0.286094 | 1.37770803 |
| hsa05163: Human cytomegalovirus infection | 23 | 2.380952 | 0.002635446 | 0.039046 | 1.98855316 |
| hsa05131: Shigellosis | 23 | 2.380952 | 0.00798429 | 0.070528 | 1.81143506 |
| hsa05170: Human immunodeficiency virus 1 infection | 22 | 2.277433 | 0.002799537 | 0.039046 | 2.01873218 |
| hsa04390: Hippo signaling pathway | 21 | 2.173913 | 1.43E-04 | 0.007682 | 2.60202539 |
| hsa04360: Axon guidance | 21 | 2.173913 | 0.001006093 | 0.029624 | 2.24460432 |
| hsa05417: Lipid and atherosclerosis | 21 | 2.173913 | 0.007047123 | 0.065855 | 1.90008365 |